This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 1999;281:1989.

In the Original Contribution entitled "The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections" published in the January 14, 1998, issue of THE JOURNAL (1998;279:130-136), the cost-effectiveness ratios in dollars for Pneumocystis carinii pneumonia and toxoplasmosis prophylaxis were incorrect. In Table 3 on page 133, the ratio should be 2300 (not 16,000) per quality-adjusted life-year saved. In Table 4 on page 134, in the analyses unadjusted for quality of life and assuming combination antiretroviral therapy, the ratios should be 1900 (not 13,000) per year of life saved; and 10,200 (not 22,000) per quality-adjusted life-year saved, respectively. In Table 6 on page 134, the ratio for strategy 2 should be 2300 (not 16,000) per quality-adjusted life-year saved. The revised data do not affect the article's policy conclusions.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?